Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Motomichi Kosuga
Observed name:
MOTOMICHI KOSUGA
Institution:
National Center For Child Health and Development
Observed institutions:
University of California, Los Angeles,
Keio University,
National Center For Child Health and Development
ORCID:
0000-0001-5226-6183
Observed ORCID:
0000-0001-5226-6183
OpenAlex ID:
A5108615426
Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase
2016
·
Motomichi Kosuga
, Ryuichi Mashima
, et al.
·
Molecular Genetics and Metabolism
·
82
Effects of idursulfase enzyme replacement therapy for Mucopolysaccharidosis type II when started in early infancy: Comparison in two siblings
2013
·
Go Tajima
, Nobuo Sakura
, et al.
·
Molecular Genetics and Metabolism
·
70
Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI
2011
·
Mahoko Furujo
, Toshihide Kubo
, et al.
·
Molecular Genetics and Metabolism
·
60
A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan
2017
·
Yasuyuki Fukuhara
, Naoko Fuji
, et al.
·
Molecular Genetics and Metabolism Reports
·
56
PDF
Engraftment of Genetically Engineered Amniotic Epithelial Cells Corrects Lysosomal Storage in Multiple Areas of the Brain in Mucopolysaccharidosis Type VII Mice
2001
·
Motomichi Kosuga
, Kyoko Sasaki
, et al.
·
Molecular Therapy
·
55
PDF
Overexpression of Bcl-2 protects human hepatoma cells from Fasantibody-mediated apoptosis
1999
·
Masahiko Takahashi
, Hidetsugu Saito
, et al.
·
Journal of Hepatology
·
54
OEIS complex with del(3)(q12.2q13.2)
2005
·
Rika Kosaki
, Yasuyuki Fukuhara
, et al.
·
American Journal of Medical Genetics Part A
·
52
Adenovirus-Mediated Gene Therapy for Corneal Clouding in Mice with Mucopolysaccharidosis Type VII
2001
·
Yuko Kamata
, Torayuki Okuyama
, et al.
·
Molecular Therapy
·
50
PDF
Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI: 10-Year follow up
2017
·
Mahoko Furujo
, Motomichi Kosuga
, et al.
·
Molecular Genetics and Metabolism Reports
·
43
PDF
Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II
2021
·
Joo-Hyun Seo
, Motomichi Kosuga
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
41
PDF
Newborn screening for Pompe disease in Japan
2011
·
Eri Oda
, Toju Tanaka
, et al.
·
Molecular Genetics and Metabolism
·
41
Natural history of cognitive development in neuronopathic mucopolysaccharidosis type II (Hunter syndrome): Contribution of genotype to cognitive developmental course
2020
·
Joo-Hyun Seo
, Torayuki Okuyama
, et al.
·
Molecular Genetics and Metabolism Reports
·
40
PDF
Adenovirus-Mediated Gene Therapy for Mucopolysaccharidosis VII: Involvement of Cross-Correction in Wide-Spread Distribution of the Gene Products and Long-Term Effects of CTLA-4Ig Coexpression
2000
·
Motomichi Kosuga
, Satori Takahashi
, et al.
·
Molecular Therapy
·
38
PDF
CT and endoscopic evaluation of larynx and trachea in mucopolysaccharidoses
2014
·
Noriko Morimoto
, Masayuki Kitamura
, et al.
·
Molecular Genetics and Metabolism
·
37
Association between the clinical presentation of congenital anomalies of the kidney and urinary tract (CAKUT) and gene mutations: an analysis of 66 patients at a single institution
2019
·
Sho Ishiwa
, Mai Sato
, et al.
·
Pediatric Nephrology
·
36
Overcoming the barriers to diagnosis of Morquio A syndrome
2014
·
Kaustuv Bhattacharya
, Shanti Balasubramaniam
, et al.
·
Orphanet Journal of Rare Diseases
·
32
PDF
Intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II: Final report of 5-year results from a Japanese open-label phase 1/2 study
2023
·
Joo-Hyun Seo
, Motomichi Kosuga
, et al.
·
Molecular Genetics and Metabolism
·
28
Strong, Long-Term Transgene Expression in Rat Liver Using Chicken β-Actin Promoter Associated with Cytomegalovirus Immediate-Early Enhancer (CAG Promoter)
2000
·
Motomichi Kosuga
, Shin Enosawa
, et al.
·
Cell Transplantation
·
28
Encapsulation Cell Therapy for Mucopolysaccharidosis Type VII Using Genetically Engineered Immortalized Human Amniotic Epithelial Cells
2006
·
Hideyuki Nakama
, Keiko Ohsugi
, et al.
·
The Tohoku Journal of Experimental Medicine
·
27
PDF
The efficacy of intracerebroventricular idursulfase‐beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology
2018
·
Young Bae Sohn
, Ah‐Ra Ko
, et al.
·
Journal of Inherited Metabolic Disease
·
26
Phenotype Correction in Murine Mucopolysaccharidosis Type VII by Transplantation of Human Amniotic Epithelial Cells after Adenovirus-Mediated Gene Transfer
2000
·
Motomichi Kosuga
, Satori Takahashi
, et al.
·
Cell Transplantation
·
26
A case of Niemann-Pick disease type C with neonatal liver failure initially diagnosed as neonatal hemochromatosis
2019
·
Tadayuki Kumagai
, Hiroshi Terashima
, et al.
·
Brain and Development
·
24
Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state
2016
·
Takashi Matsuoka
, Yoshiyuki Miwa
, et al.
·
Molecular Genetics and Metabolism Reports
·
23
PDF
Histopathological and Behavioral Improvement of Murine Mucopolysaccharidosis Type VII by Intracerebral Transplantation of Neural Stem Cells
2005
·
Yasuyuki Fukuhara
, Xiao-Kang Li
, et al.
·
Molecular Therapy
·
20
PDF
Reduction of c‐myc expression by an antisense approach under Cre/loxp switching induces apoptosis in human liver cancer cells
2001
·
Hirotoshi Ebinuma
, Hidetsugu Saito
, et al.
·
Journal of Cellular Physiology
·
20
Show more works
View as search
Works count:
83
Citation count:
1,261
H-index:
23
I10-index:
36
Year
Topic
Type